Predictive model of outcome of targeted nodal assessment in colorectal cancer

Annals of Surgery

Volumn 251, Issue 2, 2010, Pages 265-274

  Nissan, Aviram ^a,b   Protic, Mladjan ^b,c   Bilchik, Anton ^b,d   Eberhardt, John ^e   Peoples, George E ^b,f   Stojadinovic, Alexander ^b,g  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b United States Military Cancer Institute   (United States)

^c Clinical Centre of Vojvodina   (Serbia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DecisionQ Corporation   (United States)

^f BROOKE ARMY MEDICAL CENTER   (United States)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENTINEL LYMPH NODE; TREATMENT OUTCOME; ADENOCARCINOMA; BAYES THEOREM; CANCER STAGING; COLORECTAL TUMOR; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; STATISTICAL MODEL; STATISTICS;

ADENOCARCINOMA; AGED; BAYES THEOREM; COLORECTAL NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 77449133707     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181bd5187     Document Type: Article

References (36)

1. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society 2007.
2. Schneider EC, Epstein AM, Malin JL, et al. Developing a system to assess the quality of care: ASCOs National Initiative on Cancer Care Quality. J Clin Oncol. 2004;22:2985
3. National Quality Forum Endorses Consense Standards for Diagnosis and Treatment of Breast and Colorectal Cancer: National Quality Forum; first posted April 12 2007, Web based Press Release. Available at http:www.facs. org/cancer/qualitymeasures.html.
4. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006; 244:602-610.
5. Cohen Am, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer. Curr Probl Cancer. 1998;22:5-65.
6. Bilchik AJ, DiNome M, Saha S, et al. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg. 2006;141:527-533; discussion 533-534.
7. Stojadinovic A, Nissan A, Protic M, et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg. 2007;245:846-857.
8. Bembenek AE, Rosenberg R, Wagler E, et al. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg. 2007;245:858-863.
9. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg. 2004;240: 624-630.
10. Redston M, Compton CC, Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol. 2006;24:878-883.
11. Feuer EJ, Etzioni R, Cronin KA, et al. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res. 2004;13:421-442.
12. Trudeau ME, Pritchard KI, Chapman JA, et al. Prognostic factors affecting the natural history of node-negative breast cancer Breast. Cancer Res Treat. 2005;89:35-45.
13. Piccart MJ, Sotiriou C, Cardoso F. New data on chemotherapy in the adjuvant setting. Breast. 2003;12:373-378. (Pubitemid 38008646)
14. Bacus S, Chin D, Stewart J, et al. Potential use of image analysis for the evaluation of cellular predicting factors for therapeutic response in breast cancers. Anal Quant Cytol Histol. 1997;19:316-328.
15. Shen R, Ghosh D, Chinnaiyan AM. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data. BMC Genomics. 2004;5:94.
16. Cao C, Leong TY, Leong AP, et al. Dynamic decision analysis in medicine: a data-driven approach. Int J Med Inform. 1998;51:13-28.
17. Fazio VW, Tekkis PP, Remzi F, et al. Assessment of operative risk in colorectal cancer surgery: the Cleveland Clinic Foundation colorectal cancer model. Dis Colon Rectum. 2004;47:2015-2024.
18. Hudson DL, Cohen ME, Hudson SE. The use of consequential reasoning in cancer chemotherapy. Medinfo. 2001;10(pt 2):1349-1353.
19. Osuch JR, Reeves MJ, Pathak DR, et al. Clinical results from early development of a clinical decision rule for palpable solid breast masses. Ann Surg. 2003;238:728-737.
20. Saha S, Dan AG, Viehl CT, et al. Sentinel lymph node mapping in colon and rectal cancer: its impact on staging, limitations, and pitfalls. Cancer Treat Res. 2005;127:105-122.
21. Kelder W, Braat AE, Karrenbeld A, et al. The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands. Int J Colorectal Dis. 2007;22:1509-1514.
22. Codignola C, Zorzi F, Zaniboni A, et al. Is there any role for sentinel node mapping in colorectal cancer staging? Personal experience and review of the literature. Jpn J Clin Oncol. 2005;35:645-650.
23. Saha S, Monson KM, Bilchik A, et al. Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trial. Dis Colon Rectum. 2004;47:1767-1772.
24. Saha S, Dan AG, Beutler T, et al. Sentinel lymph node mapping technique in colon cancer. Semin Oncol. 2004;31:374-381.
25. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, et al. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13:1655-1663.
26. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter selective lymphadenectomy trial group. Ann Surg. 1999;230:453-463.
27. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302-311.
28. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001;233:51-59.
29. Turner RR, Nora DT, Trocha SD, et al. Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med. 2003;127:673-679.
30. Sandrucci S, Mussa B, Goss M, et al. Lymphoscintigraphic localization of sentinel node in early colorectal cancer: results of a monocentric study. J Surg Oncol. 2007;96:464-469.
31. Bendavid Y, Latulippe JF, Younan RJ, et al. Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol. 2002;79: 81-84; discussion 5.
32. Wong JH, Johnson DS, Namiki T, et al. Validation of ex vivo lymphatic mapping in hematoxylin-eosin node-negative carcinoma of the colon and rectum. Ann Surg Oncol. 2004;11:772-777.
33. Fitzgerald TL, Khalifa MA, Al Zahrani M, et al. Ex vivo sentinel lymph node biopsy in colorectal cancer: a feasibility study. J Surg Oncol. 2002;80:27-32; discussion 3.
34. Smith J, Hwang H, Wiseman KW, et al. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging? Am J Surg. 2006;191:665-668.
35. Tuech JJ, Pessaux P, Di Fiore F, et al. Sentinel node mapping in colon carcinoma: in-vivo versus ex-vivo approach. Eur J Surg Oncol. 2006;32:158-161.
36. Paramo JC, Summerall J, Poppiti R, et al. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol. 2002;9:550-554